Atrial Natriuretic Peptide (ANP-28)

Human Atrial Natriuretic Peptide

SLRRSSCFGGRMDRIGAQSGLGCNSFRY Amino Acids · MW: ~3070 Da

Ask AI About This

Amino Acids

SLRRSSCFGGRMDRIGAQSGLGCNSFRY

Molecular Weight

~3070 Da

Half-life

2-5 min

Research Score

4.2

Studies

Storage

Store lyophilized at -20°C, reconstituted at 2-8°C

What is Atrial Natriuretic Peptide (ANP-28)?

Endogenous cardiac hormone released mainly from atrial myocytes in response to stretch. It promotes natriuresis, diuresis, and vasodilation via NPR-A/guanylyl cyclase signaling.

Key Benefits & Mechanisms

natriuresis

vasodilation

cGMP elevation

Research Summary

Well-documented endogenous hormone central to blood-pressure and volume regulation; extensively studied as a biomarker and as a mechanistic probe for cGMP signaling.

Related Peptides

GLP-1(7-36) amide

Glucagon-like peptide-1 (7-36) amide

An endogenous incretin peptide released from intestinal L-cells after nutrient intake. It enhances glucose-dependent insulin secretion and slows gastric emptying, making it one of the most important gut hormones in metabolism research.

Endocrine Peptides

Cholecystokinin-8

Cholecystokinin (sulfated C-terminal octapeptide, CCK-8)

A bioactive fragment of cholecystokinin that is widely used to study GI hormone signaling. It stimulates gallbladder contraction and pancreatic enzyme secretion and is a major satiety-related gut peptide.

Endocrine Peptides

B-Type Natriuretic Peptide (BNP-32)

Human B-Type Natriuretic Peptide

Endogenous peptide hormone produced predominantly by ventricular myocardium under stretch/stress. It is a major clinical biomarker for heart failure and a potent activator of NPR-A/cGMP pathways.

Endocrine Peptides

C-Type Natriuretic Peptide (CNP-22)

Human C-Type Natriuretic Peptide

Endogenous natriuretic peptide expressed in the brain, vascular endothelium, and other tissues. It preferentially signals through NPR-B to raise cGMP and support vascular and skeletal biology.

Endocrine Peptides